Skip to main content

Oral question asked in the House of Lords, by Baroness Pidgeon (Liberal Democrat). It was answered on Wednesday, 3 June 2026.


Alzheimer’s Disease: Diagnosis and Access to Experimental Drugs

Question

My Lords, new research shows that finger-prick blood tests, alongside online brain tests, could revolutionise dementia diagnosis and offer a low-cost, scalable way to identify people who may be at higher risk of Alzheimer’s disease. What are the Government doing to support research in this area to enable the rollout of this innovative test?

Answer

The noble Baroness has touched on a really important issue. There is an enormous amount of research going into this area, for very obvious reasons. This is one area that would make so much sense, and I am sure it has been picked up. What is important about the modern service framework is that all these measures are picked up and looked at. The speed with which we can fast-track research now is a fundamental factor in supporting the outcomes we are looking for.


Secondary information

Type
Oral question
Reference
856 c834 
Session
2026-27
Oral question type
Supplementary
Chamber / Committee
House of Lords chamber
Subjects
Access Diagnosis Alzheimer's disease Drugs
Link
View this Oral question on hansard.parliament.uk